Schwann cells are essential facilitators of peripheral nerve regeneration following injury, as they provide physical support and guidance. In vitro these supporting cells are slow-growing and hence are not well suited to a tissue-engineering approach to nerve repair. We have differentiated rat bone-marrow-derived mesenchymal stem cells into Schwann-cell-like cells using a cocktail of growth factors, including glial growth factor-2. Qualitative reverse transcription-PCR, Western-blotting and immunocytochemical approaches were used to investigate the mRNA transcript levels and protein expression of glial cell markers and neurotrophic factors in differentiated mesenchymal stem cells compared with the levels found in Schwann cells (which acted as a positive control). The results showed that differentiated mesenchymal stem cells expressed transcripts and proteins for the specific glial growth receptor 2, erbB3 and neurotrophic factors, nerve growth factor, brain-derived neurotrophic factor, glialderived neurotrophic factor and leukaemia inhibitory factor. Expression of these growth factors provides further evidence that differentiated mesenchymal stem cells appear to have cellular and molecular characteristics similar to those of Schwann cells.
Introduction
It is well known that the PNS (peripheral nervous system) has a greater regenerative capacity than the central nervous system. This differing regenerative capacity is thought to be due to a greater permissive environment in the PNS, which is likely to be provided by SCs (Schwann cells) [1] . SCs have a repertoire of physiological roles, including the protection and regulation of nutritive exchanges with the axon and myelin production, and adopt a role in the digestion of the axon and myelin debris under pathological conditions [2] . SCs are powerful facilitators of peripheral nerve regeneration, as they are able to proliferate, migrate and release supporting factors during development and regeneration of the axon [3] . SCs express a range of neurotrophic factors and cell-adhesion molecules that support the regrowth of axons and reconstruction of the myelin sheath [4] .
Clearly neurotrophic factors are of clinical significance: a lack of neurotrophic factors would result in growth-cone collapse and prevent nerve regeneration. Neurotrophic factors are a diverse group of peptides involved in the development and survival of neurons; they act as maintenance factors and regulate axon outgrowth following injury. In normal intact nerves, trophic factors are produced by the target organs and they are delivered to the cell body by retrograde transport. If contact with the target organ is disrupted by injury (e.g. nerve transaction), neurotrophic factors such as NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) are produced by SCs during a process known as Wallerian degeneration [4] . This dispersed release of neurotrophic factors from SCs forms a diffused gradient around regenerating axons. Other neurotrophic factors, namely NT-3 and -4 (neurotrophins 3 and 4) and several proteins such as GDNF (glial-derived neurotrophic factor), CNTF (ciliary neurotrophic factor) and LIF (leukaemia inhibitory factor), have been also been shown to be linked to peripheral nerve survival [5] [6] [7] . An increasingly used approach for the transplantation of cultured SCs has been bioengineered conduits, and this technique has been shown to improve nerve regeneration [8] . However, using bioengineered conduits for the transplantation of SCs is a time-consuming process owing to the SC purification process required to deplete fibroblasts [9] .
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Ideally, cultured SCs should be replaced with easily accessible cells that can be rapidly expanded in culture and have SC-like properties such as the release of neurotrophic factors. One such alternative cell type is the MSC (mesenchymal stem cell), which can be differentiated into SC-like cells in culture using GGF (glial growth factor) prior to transplantation to the site of injury [10, 11] . MSCs differentiated into SClike cells can display phenotypic characteristics similar to those of SCs [11, 12] . dMSCs (differentiated MSCs) have been previously shown to express glial markers, namely GFAP (glial fibrillary acidic protein), calcium-binding protein S100 and the low-affinity neurotrophin receptor p75 [12] . However, there are no clear indications that they have a molecular profile similar to that of SCs, nor is there evidence that they can produce growth factors at the site of nerve injury. In the present study we focus on SCassociated neurotrophic factors and their expression at both the transcriptional and translational levels in dMSCs.
Experimental
All animal procedures were carried out in compliance with the U. K. Animals (Scientific Procedures) Act 1986.
Bone-marrow harvest and cultures
MSCs were harvested from the bone marrow of the femur and tibia bones of adult male Sprague-Dawley rats after terminal anaesthesia with CO 2 and cervical dislocation. The detached bones were placed in chilled αMEM (alpha modified Eagle's medium; Invitrogen) containing 1 % (w/v) penicillin/streptomycin (Invitrogen). The marrow cavity was flushed with MSC growth medium [αMEM supplemented with 10 % (w/v) FBS (foetal bovine serum; Invitrogen) and 1 % (w/v) penicillin/streptomycin] with a 21-gauge needle. The resulting cell suspension was mechanically triturated with a 21-gauge needle and passed through a 70-μm-pore-size filter (BD Falcon), followed by centrifugation (600 g for 5 min). The cell bolus was resuspended in MSC growth medium and incubated at 37
• C under 5 % CO 2 . Non-adherent (haematopoietic) cells were removed by daily washes with αMEM, allowing the adherent uMSCs (undifferentiated MSCs) to grow to confluence.
To confirm the multipotency of MSCs, cultures were treated for 3 weeks with either osteogenic induction medium (10 mM β-glycerophosphate, 0.1 μM dexamethasone, 100 μg/ml ascorbate in αMEM) or chondrogenic induction medium [0.01 nM dexamethasone, 50 μg/ml ascorbate, 40 μg/ml proline, 10 ng/ml transforming growth factor β1 (all from Sigma-Aldrich), BD ITS+ Premix universal culture supplement (containing 12.5 mg of human recombinant insulin, 12.5 mg of human transferrin, 12.5 μg of selenous acid, 2.5 g of BSA and 10.7 mg of linoleic acid) in high-glucose DMEM (Dulbecco's modified Eagle's medium; Invitrogen)] [13] . Osteoblasts and chondrocytes were stained with Alizarin Red and Toluidine Blue respectively [13, 14] .
MSC differentiation into SC-like cells
The differentiation process was initiated with subconfluent uMSCs at P4 (passage 4) with MSC growth medium supplemented with 1 mM 2-mercaptoethanol (24 h). Cells were than incubated for 72h at 37
• C under 5 % CO 2 with MSC growth medium supplemented with 35 ng/ml all-transretinoic acid (Sigma-Aldrich). The medium was replaced with MSC differentiation medium; MSC growth medium supplemented with 5.7 μg/ml forskolin (Sigma-Aldrich) and the growth factors [10 ng/ml basic fibroblast growth factor, 5 ng/ml platelet-derived growth factor-AA ('AA' refers to A-chain homodimer), both from Peprotech EC Ltd, and 126 ng/ml GGF-2 (Acorda Therapeutics Inc.)]. Cells were incubated at 37
• C under 5 % CO 2 in the differentiating medium for 2 weeks, with medium changes every 72 h to establish dMSCs [10, 11] .
SC harvest and culture
SCs were harvested from the sciatic nerves of SpragueDawley neonatal rats using a previously established protocol [8] . Briefly, the harvested nerves were placed in chilled lowglucose DMEM containing 1 % (w/v) penicillin/streptomycin. Nerves were digested with 37.5 units/ml collagenase Type I (Worthington) and 0.03 % trypsin/EDTA (Sigma-Aldrich) at 37
• C for 15 min. The enzymatic digestion was repeated for a further three cycles and stopped with SC growth medium (DMEM supplemented with 10 % FBS and 1 % penicillin/streptomycin). The digested nerves were mechanically triturated using a 21-gauge needle and passed through a 70-μm-pore-size filter (Falcon). The resulting cell suspension was centrifuged (600 g for 5 min) and plated on to 100 μg/cm poly-D-lysine (Sigma-Aldrich)-coated flasks and incubated overnight at 37
• C under 5 % CO 2 . The medium was replaced with SC growth medium containing the anti-mitotic agent 100 μM cytosine β-D-arabinofuranoside (Sigma-Aldrich) and the cultures incubated for 48 h at 37
• C under 5 % CO 2 to remove the contaminating fibroblast population. After 48 h, the medium was replaced with SC growth medium supplemented with 4.1 μg/ml forskolin and 63 ng/ml GGF-2.
Further fibroblast eradication was carried out by resuspending the SC bolus in mouse anti-(rat Thy-1.1) antibody (1:500; Serotec) and incubating at 37
• C for 10 min. Freshly prepared rabbit complement (Serotec) was added to the cell suspension and the cultures incubated for a further 30 min with gentle agitation every 10 min. The cells were centrifuged at 600 g for 5 min, plated on poly-D-lysinecoated flasks and incubated at 37
• C under 5 % CO 2 .
Preparation of total RNA
At confluence, the desired-passage-number cells (uMSCs, dMSCs and SCs) were harvested by treatment with 0.25 % trypsin/EDTA at 37
• C for 5 min and centrifugation at 600 g for 5 min). The RNeasy TM Mini Kit (Qiagen) was used for the isolation of total RNA from the cell pellets as per the manufacturer's protocol. DNase I (Qiagen) digestion was performed while the nucleic acids were bound to the RNeasy TM column. The RNA was eluted into 50 μl of RNase-free water. The quality and integrity of the RNA was assessed by agarose-gel electrophoresis. The RNA concentrations were determined by UV spectrophotometry using a UV 1101 Biotech photometer (WPA).
RT-PCR (reverse transcription-PCR)
Each PCR primer pair was designed such that the forward and reverse primers anneal to different exons ( Table 1 ). The primers were synthesized by Invitrogen Life Technologies. The optimum annealing temperature for each primer pair was determined experimentally. The One-Step RT-PCR kit (Qiagen) was used for all RT-PCRs. A master mix was prepared in RNase-free water to give the following final concentrations of components: 5 × Qiagen One Step RT-PCR Buffer, 400 μM dNTPs, 0.6 μM forward primer, 0.6 μM reverse primer, 5-10 units of enzyme mix and 1 ng of template RNA or RNase-free water (negative control). An MJ Research PTC-200 (gradient) cycler was used for all reactions. The cycling parameters were as follows: an RT step (50
• C for 30 min), a nucleic acid denaturation/reversetranscriptase-inactivation step (95
• C for 15 min) followed by 35 cycles of denaturation (95
• C for 30 s each), annealing (30 s; for temperatures, see Table 1 ) and primer extension (72
• C for 1 min), followed by final-extension incubation (72
• C for 5 min). A qualitative assessment of the integrity and size of the PCR amplicons from the one-step RT-PCRs was performed using 2%-(w/v)-agarose-gel electrophoresis at 50 V for 90 min in 1 × TAE (Tris/acetic acid/EDTA) buffer (1 litre of 50 × TAE contains 242 g of Tris base, 57.1 ml of 100 % acetic acid and 100 ml of 0.5 M EDTA, pH 7.6-7.8). The size of the PCR products was estimated using Hyperladder IV (Bioline). The agarose gel was soaked in 0.5 mg/ml ethidium bromide (Sigma-Aldrich), washed, and observed under UV transillumination. The images were captured using an AlphaImager 2200 (AlphaInnotech) gel-documentation system. The RT-PCR procedure was repeated for each of the glial markers and neurotrophic factors for each of the three cell types (n = 5).
The DNA sequence of each amplicon was confirmed using the Big Dye TM Terminator Sequencing Kit (Applied Biosystems Inc.) and protocol, followed by sequence analysis on the Prism 3100 Genetic Analyzer (Applied Biosystems Inc.). The primer shown has minor changes compared with that used in the cited paper.
Biphasic PCR
It proved necessary to use biphasic PCR methodology to detect the low-level transcripts of GFAP and p75 in the cell types investigated above. Following RT-PCR amplification (first round) of the p75 and GFAP transcripts, the reaction products were purified using a QiaQuick PCR Clean-Up kit (Qiagen). The first-round products were re-amplified using a standard PCR kit (Bioline). The resulting products were subjected to agarose-gel electrophoresis and DNA sequencing to verify their identity. This approach was repeated for all transcripts to confirm the results for all glial markers and neurotrophic factors.
Immunocytochemistry of cultured cells
The three cell types (uMSCs, dMSCs and SCs) were cultured for 24 h on slide flasks (Fisher Scientific) and fixed in 4 % (w/v) paraformaldehyde at 4
• C for 20 min. The cells were blocked in normal goat serum (Sigma-Aldrich) and incubated overnight at 4
• C with primary antibodies to one of the following: erbB3 [v-erb-b2 erythroblastic leukaemia viral oncogene homologue 3 (avian); mouse monoclonal; 1:50; Santa Cruz], neurotrophic factors (NGF, BDNF and LIF; all rabbit polyclonal; 1:500; Santa Cruz) or GDNF (rabbit polyclonal; 1:500; Abcam).
On the following day the cells were incubated at 21
• C for 2 h with secondary antibodies: FITC-conjugated goat anti-rabbit (1:100; Vector Laboratories) for NGF, BDNF, GDNF, LIF and fluorescent-dye-Cy3-conjugated goat antimouse (1:200; Amersham) for erbB3. The cells were mounted using Vectashield TM for fluorescence with DAPI (4 ,6-diamidino-2-phenylindole) for nuclear staining (Vector Laboratories). The slides were examined under a fluorescence microscope (Olympus BX60) at × 40 magnification and captured using Image-Pro Plus Imaging software (Media Cybernetics).
Western blotting of whole-cell protein lysates
Whole-cell lysates were prepared from cells cultured to confluence. Cell pellets were resuspended in whole-cell lysis buffer [100 mM Pipes (1,4-piperazinediethanesulfonic acid), 5 mM MgCl 2 , 5 mM EGTA, 20 % (v/v) glycerol, 0.5 % (v/v) Triton X-100 and 0.005 % protease-inhibitor cocktail (all Sigma-Aldrich)] and incubated on ice (15 min). Protein concentration was determined using the DC protein assay system (Bio-Rad Laboratories) as per the manufacturer's protocol.
Proteins were denatured in Laemmli buffer at 95
• C for 5 min and separated by SDS/10%-(w/v)-PAGE (for erbB3) or SDS/15%-(w/v)-PAGE (for BDNF, GDNF and LIF) at 120 V using the Bio-Rad Mini-Protean 3 and Transblot system (BioRad Laboratories). The separated proteins were transferred on to nitrocellulose membrane at 30 V for 90 min in transfer buffer; their transfer was verified by staining with Ponceau Red (Sigma-Aldrich). The membranes were blocked (1 h) in 5 % (w/v) dried skimmed milk powder (Marvel) in TBS/Tween (10 mM Tris base, pH 7.5, 100 mM NaCl and 0.1 % Tween 20) and incubated for 4
• C overnight with either anti-erbB3 (mouse monoclonal; 1:200; Santa Cruz), anti-NGF, anti-BDNF, anti-LIF (all rabbit polyclonal; 1:500; Santa Cruz) or anti-GDNF (rabbit polyclonal; 1:500; Abcam]. Additionally, anti-GAPDH [anti-(glyceraldehyde-3-phosphate dehydrogenase); mouse monoclonal; 1:5000; Abcam) was used as a loading control. The membranes were incubated at 21
• C for 1 h with HRP (horseradish peroxidase)-conjugated secondary antibodies (horse anti-mouse at 1:1000 for erbB3 and GAPDH or horse anti-rabbit at 1:2000 for NGF, BDNF, GDNF and LIF) and treated with ECL ® (enhanced chemiluminescence) HRP substrate (Amersham Biosciences). The membranes were subjected to autoradiography by exposure to Kodak X-OMAT light-sensitive film.
Statistical analysis
The blots were analysed using Scion Image software (Scion Corporation). Statistical analysis for Western-blot data was conducted using GraphPad Prism software (GraphPad Software Inc.). Data are expressed as means + S.E.M. and were subjected to one-way ANOVA followed by Bonferroni's Multiple Comparison Test.
Results

Multipotency of MSCs
The cultured bone-marrow-derived uMSCs adhered to plastic and displayed a flattened fibroblast-like morphology (Figure 1 ). The multipotency of MSCs was demonstrated by their ability to differentiate into osteoblasts and chondrocytes, which is indicated by positive Alizarin Red staining for mineralized bone ( Figure 1A ) and Toluidine Blue staining for cartilage matrix ( Figure 1B) respectively. MSCs begin to undergo morphological changes during growth-actorinduced differentiation at P4 ( Figure 1D ) and, following full differentiation, MSCs display a spindle-like morphology ( Figure 1E ) similar to that of cultured SCs ( Figure 1F ).
RNA expression
The presence of the glial-cell marker and neurotrophicfactor gene transcripts was assessed using qualitative RT-PCR methodology ( Figure 2) . As a control, the results show that dMSCs, like SCs, express the transcripts for S100 (211 bp), p75 (438 bp), GFAP (391 bp) and nestin (327 bp).
The results also show that dMSCs express transcripts of NGF (440 bp), BDNF (574 bp), GDNF (400 bp) and LIF (333 bp), but not CNTF (predicted amplicon size of 610 bp) compared with SCs. In addition to the neurotrophic factors expressed by MSCs, the SCs express CTNF. Interestingly, the dMSCs showed greater expression of BDNF than the SCs. By contrast, uMSCs, like dMSCs and SCs, express BDNF, GDNF and LIF, but not CNTF. As expected, none of the three cell types, uMSCs, dMSCs or SCs, express NT-3 or NT-4 (predicted amplicon sizes of 661 bp and 443 bp). The RT-PCR amplification efficacy of the mRNA was confirmed by the amplification of the GAPDH (333 bp) housekeeping gene (Figures 2 and 3) . The identity of the amplicons was confirmed by sequencing (results not shown).
Immunocytochemistry
Immunocytochemical staining showed that SCs expressed erbB3 ( Figure 3C) , with dMSCs expressing 70 % positive for erbB3 ( Figure 3B ), whereas uMSCs showed only 5 % positive immunostaining ( Figure 3A) . The dMSCs ( Figures 4B, 4E , 4H and 4K) showed similar 100 % positive immunostaining for NGF, BDNF, GDNF and LIF compared with SCs ( Figures 4C, 4F, 4I and 4L ). By contrast, uMSCs were negative for GDNF ( Figure 4G ) and showed weak immunostaining for NGF, BDNF and LIF, which were 20 % positive ( Figures 4A, 4D and 4J) .
Protein expression
Densitometric analysis of the dMSC lysates for erbB3 (180 kDa) was performed by analysis of the autoradiographic bands and normalized by taking the ratio between the density of the erbB3 band and that of GAPDH (40 kDa; Figure 5 ). The findings supported the results of immunocytochemical staining and indicated that dMSCs show a 4-fold increase (P < 0.01) in erbB3 protein expression compared with the uMSCs.
Similarly, densitometric analysis of the lysates for the expression of the neurotrophic factors, NGF [13 kDa (mature) and 27 kDa (precursor)], BDNF (20 kDa), GDNF (24 kDa) and LIF (45 kDa) was performed, taking the ratio of band density to that of GAPDH ( Figure 6 ). GAPDH expression was consistently similar in all cell types for each experiment. All cell types expressed both the mature and the precursor forms of NGF ( Figure 6A) . The dMSCs showed a 2-fold increase in the NGF precursor compared with uMSCs (P < 0.05), but the levels were not significantly different from those in SCs. However, dMSCs showed a 6-fold increase in BDNF ( Figure 6B ) and GDNF ( Figure 6C ) compared with uMSCs (P < 0.001). Also, dMSCs showed a 4-fold increase in BDNF compared with SCs (P < 0.01). The level of GDNF in dMSCs is lower compared with that in SCs (P < 0.05), but significantly higher than in uMSCs (P < 0.001). All cell types expressed LIF ( Figure 6D) , with dMSC showing a 4-fold increase compared with uMSCs (P < 0.01) and no significant difference when compared with SCs. The markers in the three cell types (uMSCs, dMSCs and SCs) assessed by 2%-agarose electrophoresis were S100, GFAP, p75, nestin, NGF, BDNF, GDNF, LIF, CNTF, NT-3, NT-4 and GAPDH).
* indicates biphasic PCR products used for increased detection sensitivity.
Discussion
The results of the present study provided extensive cellular and molecular characterization of MSCs differentiated into SCs. The characterization is essential before the cells can be considered suitable and clinically useful substitutes for SCs in peripheral nerve repair. Currently, the differentiation of MSCs into SC-like cells is achieved using an established cocktail of growth factors [11, 12] . More interestingly, we have extended the findings and investigated the GGF-2 receptor, erbB3 and the expression of neurotrophic factors that are associated with SCs at the transcriptional and translational levels.
Differentiation of MSCs into SC-like cells was confirmed by the expression of transcripts for glial markers previously investigated [12] . The level of transcripts GFAP, S100 and p75 in dMSCs were at levels similar to those in SCs, whereas the uMSCs did not express any of these glial markers, as described by others [15] . However, the transcript levels of the intermediate-filament protein nestin are expressed by uMSCs and appear to be slightly downregulated following differentiation, a finding that provides a further indication that MSCs may be programmed along the chosen neural lineage [16] [17] [18] . Although the effect of cell age was not extensively investigated in the present study, previous studies by our group have demonstrated that cells differentiated at different passages did not differ in respect of nestin expression [12] . We therefore hypothesize that glial-cell protein marker expression remains constant over time throughout the differentiation period.
Numerous studies have shown that MSCs express glialcell markers following differentiation with GGF-2 in vitro (see, e.g. [11, 19] ). In vivo, however, GGF-2 is secreted by neuronal cells, is strongly associated with SCs, is trophic for SC precursors and, at high concentrations, drives their proliferation and maturation [3] . GGF-2 belongs to a group of proteins known as neuregulins, which act through the erbB3 receptor in SCs and is essential for survival [20] . The upregulation of the GGF-2 receptor erbB3 receptor protein in dMSCs was noted following differentiation. erbB3 plays an important role in development and regeneration of the peripheral nervous system by transducing the signal of SCs and, in the present study, possibly dMSCs [21, 22] . One possibility is that forskolin acts as an adenylate cyclase activator and indirectly activates the transcription of the erbB3 receptor and enhances its response to GGF-2 and explains its lack of expression in uMSCs [21, 23] . Our previous studies have shown that forskolin is necessary for the differentiation of MSCs into SCs, as its omission from the culture medium led to the cells failing to differentiate. Interestingly, neuregulins continue to be expressed during adulthood, which suggests that they may have additional roles in peripheral nerve maintenance as well as in regeneration [3] . The transcript and protein expression of neurotrophic factors known to be associated with SCs in neuron survival and regeneration was investigated. Western-blot analysis also supported the notion that the expression of these proteins was not artefactual or due to cell shrinkage [12, 24] . The results showed that, like SCs, dMSCs and uMSCs expressed the transcripts and proteins for NGF, BDNF, GDNF and LIF. NGF is the predominant neurotrophic factor released by SCs in the intact PNS, suggesting that dMSCs are indeed differentiated into SCs. Physiologically, NGF is retrogradely transported to the cell body in the intact PNS, but, following axotomy, NGF is up-regulated, with a peak after 24 h that is maintained for at least 2 weeks [4] . This high level of NGF production by SCs is regulated by interleukin-1 released from macrophages which had invaded nerves during Wallerian degeneration [25] . Whereas BDNF is not substantially expressed in the SCs of intact peripheral nerves but following axotomy, expression of BDNF rapidly increases to reach maximum binding within 3-4 days following axotomy [4] . Although the BDNF transcript is predominant in both uMSCs and dMSCs, the protein expression in dMSCs is strongly positive. The results for the expression of NGF and BDNF by dMSCs are consistent with the findings of others and suggest possible functional roles [26] . The elevation in dMSCs of NGF and especially BDNF, which is strongly expressed, supports the notion that these two factors may be responsible for the similar promotion of neurite outgrowth and growth patterns observed in dMSCs and SCs when cocultured with primary sensory neurons [12] . Therefore, in their undifferentiated state, MSCs may not be releasing levels of neurotrophic factors sufficient to cause an SC-like effect and possible SC-specific roles. Such roles may be enhanced by the expression of S100 and GFAP, proteins that are known to have essential proliferative roles in SCs [27, 28] .
All cell groups expressed the GDNF transcript, but lower levels were observed in uMSCs. This difference was also reflected in the expression of the GDNF protein, which is only seen in dMSCs and SCs. GDNF has been shown to have a role in the migration of SCs and the promotion of neuronal survival, since it is up-regulated following nerve regeneration through association with the neural cell-adhesion molecule [29] . There was a similar level of LIF transcript present in all three groups, but the expression of LIF protein was greater following differentiation. LIF is an autocrine survival factor that potentiates neuregulin support and is up-regulated by SCs following nerve injury and likewise in dMSCs [30, 31] . Hence the transcript expression of LIF in all cell groups may reflect the survival potential of this growth factor, which is only expressed as a full protein in SCs and dMSCs. The lack of CNTF expression by dMSCs and SCs may be due to the absence of axonal contact by the cultured cells rather than a lack of ability to express CTNF. This notion is supported by numerous studies that have shown that CNTF production by SCs requires axonal contact and is decreased following axotomy [32] [33] [34] . The low transcript expression of CNTF in SCs may be residual following their isolation from the nerve, and this would explain its absence in dMSCs and uMSCs. Our results are consistent with those obtained in previous studies showing that human MSCs express transcripts encoding for BDNF but not NT-3 or NT-4 [35] . The absence of NT-3 and NT-4 would be expected in vitro, since SCs do not express these growth factors in vivo under physiological conditions [7] .
Overall these findings show that MSCs are capable of expressing neurotrophic factors in a way similar to SCs [36] . We believe the up-regulation of neurotrophic factors in Figure 6 Western-blot and densitometric analysis of neurotrophic-factor expression in cultured uMSCs, dMSCs and SCs (A) NGF, mature and precursor forms; (B) BDNF; (C) GDNF; and (D) LIF. Values are means + S.E.M. and are density ratios compared with GAPDH.
* P < 0.05; * * P < 0.01; * * * P < 0.001. differentiated MSCs will allow these cells to mimic key SClike roles and be functionally useful following nerve injury repair. The results of the present study and previous studies by our group have shown that dMSCs display the phenotypic, molecular and functional therapeutically useful traits of SCs.
